|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. CA Cancer J Clin. 65:5–29. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kverneng Hultberg D, Svensson J, Jutesten
H, Rutegård J, Matthiessen P, Lydrup ML and Rutegård M: The impact
of anastomotic leakage on long-term function after anterior
resection for rectal cancer. Dis Colon Rectum. 63:619–628.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Smith JD, Butte JM, Weiser MR, D'Angelica
MI, Paty PB, Temple LK, Guillem JG, Jarnagin WR and Nash GM:
Anastomotic leak following low anterior resection in stage IV
rectal cancer is associated with poor survival. Ann Surg Oncol.
20:2641–2646. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hain E, Maggiori L, Manceau G, Mongin C,
Prost À la Denise J and Panis Y: Oncological impact of anastomotic
leakage after laparoscopic mesorectal excision. Br J Surg.
104:288–295. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Karim A, Cubas V, Zaman S, Khan S, Patel H
and Waterland P: Anastomotic leak and cancer-specific outcomes
after curative rectal cancer surgery: A systematic review and
meta-analysis. Tech Coloproctol. 24:513–525. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhou X, Wang B, Li F, Wang J and Fu W:
Risk factors associated with nonclosure of defunctioning stomas
after sphincter-preserving low anterior resection of rectal cancer:
A meta-analysis. Dis Colon Rectum. 60:544–554. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ashraf SQ, Burns EM, Jani A, Altman S,
Young JD, Cunningham C, Faiz O and Mortensen NJ: The economic
impact of anastomotic leakage after anterior resections in English
NHS hospitals: Are we adequately remunerating them? Colorectal Dis.
15:e190–e198. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hammond J, Lim S, Wan Y, Gao X and Patkar
A: The burden of gastrointestinal anastomotic leaks: An evaluation
of clinical and economic outcomes. J Gastrointest Surg.
18:1176–1185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Meyer J, Naiken S, Christou N, Liot E,
Toso C, Buchs NC and Ris F: Reducing anastomotic leak in colorectal
surgery: The old dogmas and the new challenges. World J
Gastroenterol. 25:5017–5025. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kawada K and Sakai Y: Preoperative,
intraoperative and postoperative risk factors for anastomotic
leakage after laparoscopic low anterior resection with double
stapling technique anastomosis. World J Gastroenterol.
22:5718–5727. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qu H, Liu Y and Bi DS: Clinical risk
factors for anastomotic leakage after laparoscopic anterior
resection for rectal cancer: A systematic review and meta-analysis.
Surg Endosc. 29:3608–3617. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rink AD, Kienle P, Aigner F and Ulrich A:
How to reduce anastomotic leakage in colorectal surgery-report from
German expert meeting. Langenbecks Arch Surg. 405:223–232.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xu R, Won JY, Kim CH, Kim DE and Yim H:
Roles of the phosphorylation of transcriptional factors in
epithelial-mesenchymal transition. J Oncol.
2019(5810465)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ricard-Blum S: The collagen family. Cold
Spring Harb Perspect Biol. 3(a004978)2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ohlund D, Lundin C, Ardnor B, Oman M,
Naredi P and Sund M: Type IV collagen is a tumour stroma-derived
biomarker for pancreas cancer. Br J Cancer. 101:91–97.
2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Qiu S, Deng L, Liao X, Nie L, Qi F, Jin K,
Tu X, Zheng X, Li J, Liu L, et al: Tumor-associated macrophages
promote bladder tumor growth through PI3K/AKT signal induced by
collagen. Cancer Sci. 110:2110–2118. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liang Y, Lv Z, Huang G, Qin J, Li H, Nong
F and Wen B: Prognostic significance of abnormal matrix collagen
remodeling in colorectal cancer based on histologic and
bioinformatics analysis. Oncol Rep. 44:1671–1685. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xu S, Xu H, Wang W, Li S, Li H, Li T,
Zhang W, Yu X and Liu L: The role of collagen in cancer: From bench
to bedside. J Transl Med. 17(309)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Libra M, Scalisi A, Vella N, Clementi S,
Sorio R, Stivala F, Spandidos DA and Mazzarino C: Uterine cervical
carcinoma: Role of matrix metalloproteinases (review). Int J Oncol.
34:897–903. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Murphy G: Tissue inhibitors of
metalloproteinases. Genome Biol. 12(233)2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Medina C and Radomski MW: Role of matrix
metalloproteinases in intestinal inflammation. J Pharmacol Exp
Ther. 318:933–938. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
DI Carlo A: Matrix metalloproteinase-2 and
-9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and
urine of patients with renal carcinoma. Oncol Lett. 7:621–626.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Herszényi L, Hritz I, Lakatos G, Varga MZ
and Tulassay Z: The behavior of matrix metalloproteinases and their
inhibitors in colorectal cancer. Int J Mol Sci. 13:13240–13263.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Knight CD and Griffen FD: An improved
technique for low anterior resection of the rectum using the EEA
stapler. Surgery. 88:710–714. 1980.PubMed/NCBI
|
|
28
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Le CC, Bennasroune A, Langlois B, Salesse
S, Boulagnon-Rombi C, Morjani H, Dedieu S and Appert-Collin A:
Functional interplay between collagen network and cell behavior
within tumor microenvironment in colorectal cancer. Front Oncol.
10(527)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yuzhalin AE, Lim SY, Kutikhin AG and
Gordon-Weeks AN: Dynamic matrisome: ECM remodeling factors
licensing cancer progression and metastasis. Biochim Biophys Acta
Rev Cancer. 1870:207–228. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yuzhalin AE, Urbonas T, Silva MA, Muschel
RJ and Gordon-Weeks AN: A core matrisome gene signature predicts
cancer outcome. Br J Cancer. 118:435–440. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Naba A, Clauser KR, Whittaker CA, Carr SA,
Tanabe KK and Hynes RO: Extracellular matrix signatures of human
primary metastatic colon cancers and their metastases to liver. BMC
Cancer. 14(518)2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Skovbjerg H, Anthonsen D, Lothe IM, Tveit
KM, Kure EH and Vogel LK: Collagen mRNA levels changes during
colorectal cancer carcinogenesis. BMC Cancer. 9(136)2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Buch AS, Schjerling P, Kjaer M, Jorgensen
LN, Krarup PM and Ågren MS: Impaired collagen synthesis in the
rectum may be a molecular target in anastomotic leakage
prophylaxis. Wound Repair Regen. 25:532–535. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zou X, Feng B, Dong T, Yan G, Tan B, Shen
H, Huang A, Zhang X, Zhang M, Yang P, et al: Up-regulation of type
I collagen during tumorigenesis of colorectal cancer revealed by
quantitative proteomic analysis. J Proteomics. 94:473–485.
2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang Q, Feng M, Ma X, Li H and Xie W: Gene
expression profile comparison between colorectal cancer and
adjacent normal tissues. Oncol Lett. 14:6071–6078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Springer NL, Iyengar NM, Bareja R, Verma
A, Jochelson MS, Giri DD, Zhou XK, Elemento O, Dannenberg AJ and
Fischbach C: Obesity-Associated extracellular matrix remodeling
promotes a macrophage phenotype similar to tumor-associated
macrophages. Am J Pathol. 189:2019–2035. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Vellinga TT, den Uil S, Rinkes IH, Marvin
D, Ponsioen B, Alvarez-Varela A, Fatrai S, Scheele C, Zwijnenburg
DA, Snippert H, et al: Collagen-rich stroma in aggressive colon
tumors induces mesenchymal gene expression and tumor cell invasion.
Oncogene. 35:5263–5271. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yamada T, Oshima T, Yoshihara K, Tamura S,
Kanazawa A, Inagaki D, Yamamoto N, Sato T, Fujii S, Numata K, et
al: Overexpression of MMP-13 gene in colorectal cancer with liver
metastasis. Anticancer Res. 30:2693–2699. 2010.PubMed/NCBI
|
|
40
|
Hasty KA, Pourmotabbed TF, Goldberg GI,
Thompson JP, Spinella DG, Stevens RM and Mainardi CL: Human
neutrophil collagenase. A distinct gene product with homology to
other matrix metalloproteinases. J Biol Chem. 265:11421–11424.
1990.PubMed/NCBI
|
|
41
|
Böckelman C, Beilmann-Lehtonen I, Kaprio
T, Koskensalo S, Tervahartiala T, Mustonen H, Stenman UH, Sorsa T
and Haglund C: Serum MMP-8 and TIMP-1 predict prognosis in
colorectal cancer. BMC Cancer. 18(679)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Schmalz G, Davarpanah I, Jäger J, Mausberg
RF, Krohn-Grimberghe B, Schmidt J, Haak R, Sack U and Ziebolz D:
MMP-8 and TIMP-1 are associated to periodontal inflammation in
patients with rheumatoid arthritis under methotrexate
immunosuppression-First results of a cross-sectional study. J
Microbiol Immunol Infect. 52:386–394. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lee JH, Choi JW and Kim YS: Plasma or
serum TIMP-1 is a predictor of survival outcomes in colorectal
cancer: A meta-analysis. J Gastrointestin Liver Dis. 20:287–291.
2011.PubMed/NCBI
|
|
44
|
Park KS, Kim SJ, Kim KH and Kim JC:
Clinical characteristics of TIMP2, MMP2 and MMP9 gene polymorphisms
in colorectal cancer. J Gastroenterol Hepatol. 26:391–397.
2011.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hilska M, Roberts PJ, Collan YU, Laine VJ,
Kössi J, Hirsimäki P, Rahkonen O and Laato M: Prognostic
significance of matrix metalloproteinases-1, -2, -7 and -13 and
tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in
colorectal cancer. Int J Cancer. 121:714–723. 2007.PubMed/NCBI View Article : Google Scholar
|
